Peripheral Vascular Devices Market: Growth, Size, Share, and Trends

Report Code MD 1254
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029

Overview

The global peripheral vascular devices market, valued at US$10.94 billion in 2023, is forecasted to grow at a robust CAGR of 5.2%, reaching US$11.43 billion in 2024 and an impressive US$14.73 billion by 2029.

Several factors drive growth in this peripheral vascular devices market. A pertinent factor is the incidence of peripheral artery disease and other vascular diseases, which is rising, primarily because of an aging population but also due to risk factors such as diabetes, hypertension, and obesity. It is quite natural that, as these conditions become more common worldwide, the demand for effective treatments will increase, namely, stents, balloons, and catheters. These devices also become more attractive to patients and healthcare providers because of technological advancements in device design, including better patient outcomes and minimally invasive procedures that reduce recovery time and complications through drug-eluting stents.A better method of screening, which has led to a much higher awareness and diagnosis of peripheral vascular diseases, reflects the fact that interventions can occur much earlier. This, therefore, increases the total procedures that will require peripheral vascular devices in general.

Attractive Opportunities in the Peripheral Vascular Devices Market

Asia Pacific

The growth in the Asia Pacific region is driven by the high rise of the diabetic population and increasing obesity in the population.

Increasing prevalence of peripheral artery diseases in the population due to sedentary lifestyles, smoking habits, and high consumption of unhealthy fats.

Government reimbursements and awareness programs help in diagnosing and screening diseases like PAD.

Emerging markets such as China, India, Brazil, South Korea, and Australia are offering high growth opportunities for players operating in this market

North America accounted for the largest market share due to the fast adoption of advanced technologies the high incidence rate of diseases like PAD and other co-morbidities.

Global Peripheral Vascular Devices Market Dynamics

Driver: Increased prevalence of Diabetes amongst the population

There is a growing influence of the diabetes epidemic that has become the major driver of the growth of the peripheral vascular devices market; diabetes has an excellent association with PAD. Diabetes causes damage to blood vessels through a process that involves induction by inflammation caused by hyperglycemia and atherosclerosis involving the build-up of plaque inside arteries, a condition that exposes diabetics to developing PAD and other peripheral vascular diseases that impair blood circulation mainly in the lower extremities. A concomitant rise in the number of people living with diabetes also translates to an increase in the incidence of PAD and its resultant complications, such as critical limb ischemia and amputations. To take care of the issues above, interventions in stents, angioplasty balloons, and the use of atherectomy devices are needed to ensure that there's proper blood flow coming through again; these diabetes cases bring about push the pace for peripheral vascular devices-based minimally invasive treatments, which are therefore becoming a mandate in the handling of complicated diabetic cases.

Restraint: Product recalls

An increased number of product recalls is a major restriction for the peripheral vascular devices market. The recall is mostly prompted by failures or safety issues such as malfunctioning, poor design, or adverse effects on the patients. These increase the erosion of consumer confidence and also create fearfulness among healthcare providers when embracing a new or an existing device. They also result in scrutiny of regulations and delay the approval of the products, therefore limiting the entry of new devices. They also result in legal liabilities, financial losses for the manufacturers, and high costs of correction or replacement of faulty devices. All these contribute negatively to market growth and the adoption rate of peripheral vascular devices, particularly when frequently recalled leading manufacturers are involved.

 

Opportunity: High growth rate in emerging markets

The immense opportunity available in the peripheral vascular devices market is attributed to high growth rates in emerging markets due to a variety of factors. Since the past few years, healthcare expenditure and infrastructure development in the medical fields have been significantly rising in regions like Asia-Pacific, Latin America, and the Middle East, providing people with better access to advanced medicinal treatments such as peripheral vascular interventions. This disease pool is augmenting enormously with the increasing prevalence of lifestyle diseases such as diabetes, hypertension, and obesity within these regions. The modernization of the healthcare system in the markets is ongoing, and emerging new technologies such as drug-eluting stents and atherectomy devices are creating demand for minimally invasive technologies. Governments and the private sectors have invested in healthcare infrastructure, which has increased the adoption of advanced medical devices; consequently, the market has expanded. Other benefits of these areas comprise greater low-cost manufacturing and market access opportunities for companies operating globally.

Challenge: Regulatory landscape for medical devices

The heterogeneity in the regulatory landscape that characterizes this industry proves to be a huge challenge, as it is very complex and stringent, needing high-level clinical trials to prove the safety and efficacy of the products. Companies experience variability in the regulations followed in different regions, thereby causing inconsistency in approval timelines and requirements, thus complicating access to international markets. Additionally, the high costs associated with meeting the regulatory requirements are very difficult and as new standards emerge, necessitating or modifying products is a task for the manufacturers.

Global Peripheral Vascular Devices Market Ecosystem Analysis

 

The angioplasty stent market segment witnessed the highest growth during the forecast period.

Based on type, the peripheral vascular devices segment is segmented into - Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices and Other peripheral vascular devices. Angioplasty stents, however, are all of the above extensively used and occupy the market of balloons, catheters, hemodynamic flow alteration devices, and plaque modification tools. They provide a more comprehensive, long-lasting remedy for blocked or narrowed arteries. Balloon angioplasty may dilate an artery temporarily by filling it and compressing the plaque; however, the artery usually risks restenosis, re-narrowing, later.

Furthermore, there is the drug-eluting stent, a development that dispenses medication when introduced into the body to prevent tissue from forming, which might cause the artery walls to narrow again. Stents are also minimally invasive, therefore with lesser recovery time and complications in comparison to more invasive procedures. The versatility of stents with the ability to combine with other technologies such as drug-coated balloons and the historical success in both coronary and peripheral artery treatments will be factors that provide more leeway for a larger market share. This reliability and wide applicability make stents a preferred choice for vascular interventions, hence securing more dominance in the market.

 

North America accounted for the largest share of the Peripheral vascular devices market in 2023.

North America is one of the leading markets for peripheral vascular devices, and there are several significant reasons behind it being so. The region is reported to be very well-developed with regard to health care infrastructure, having better hospitals and special clinics that can easily adopt and integrate new vascular technologies and treatments. Leading medical device manufacturers from the U.S., like Medtronic, Abbott, and Boston Scientific, ensure constant growth of the market owing to their continuous innovation and easy access to the latest and greatest devices.

The prevalence of cardiovascular diseases, including PAD, is also high in North America, where factors such as a growing old-age population, an increase in obesity, smoking, and diabetes are prevalent. This offers a large pool of patients, who due to the pressures of these conditions require vascular interventions, thereby increasing the demand for devices such as stents, balloons, and catheters. The region also draws benefits from favorable reimbursement policies and insurance coverage, thereby facilitating greater access to procedures by patients, thus introducing advanced devices at wider levels.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION

Recent Developments of Peripheral Vascular Devices Market

  • In April 2023, Medtronic launched the IN. PACT AV Drug-Coated Balloon to treat restenosis in patients undergoing AV fistula interventions.
  • In Jan 2023, Boston Scientific Corporation Introduced a Ranger Drug Coated Balloon to treat peripheral artery disease. This device delivers paclitaxel, which reduces the chance of artery re-narrowing, offering a lower-dose treatment option with proven effectiveness for PAD patients.

Key Market Players

KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICES MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Peripheral Vascular Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024–2029
Forecast units Value (USD Million)
Segments covered By Tye and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, Brazil, Middle East & Africa

 

Key Questions Addressed by the Report

What is the expected addressable market value of the Peripheral vascular devices market over 5 years?
The Peripheral vascular devices market is projected to reach USD 14.7 billion by 2029, at a CAGR of 5.2% during the forecast period.
Which segment is expected to garner the highest traction within the Peripheral vascular devices market?
The angioplasty stent segment is expected to witness the highest growth in the Peripheral vascular devices market.
Which segment is expected to garner the highest growth rate traction within the Peripheral vascular devices market?
The Hemodynamic flow alteration devices segment is expected to register the highest growth rate during the forecast period.
What are the strategies adopted by the top market players to penetrate emerging regions?
The major players in the market use partnerships, distribution agreements, product launches, and product approvals as important growth tactics.
What are the major factors expected to limit the growth of the Peripheral vascular devices market?
The stringent regulatory scenario and approvals for peripheral vascular devices are major limiting factors for the growth of the market.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Peripheral Vascular Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
28
RESEARCH METHODOLOGY
33
EXECUTIVE SUMMARY
46
PREMIUM INSIGHTS
51
MARKET OVERVIEW
53
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rapid growth in geriatric population and subsequent increase in disease prevalence
    - Favorable reimbursement scenario for procedures
    - Increased prevalence of diabetes
    - Rising rate of tobacco consumption
    - Growing incidence of obesity
    OPPORTUNITIES
    - High growth potential in emerging markets
    CHALLENGES
    - Availability of alternative treatments
    - Dearth of skilled professionals with expertise in peripheral vascular devices
    - Product failures and recalls
  • 5.3 INDUSTRY TRENDS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 PORTER’S FIVE FORCE ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS
    BUYING CRITERIA
  • 5.9 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Drug-eluting stents
    - Atherectomy devices
    COMPLEMENTARY TECHNOLOGIES
    - Intravascular ultrasound
    - Optical coherence tomography
    ADJACENT TECHNOLOGIES
    - Remote patient monitoring
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.12 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE, BY KEY PLAYERS
  • 5.13 REIMBURSEMENT ANALYSIS
  • 5.14 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.15 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.16 CASE STUDIES
    CASE STUDY 1: DRUG-COATED BALLOON HELPING IN REDUCING RESTENOSIS
    CASE STUDY 2: IMPROVED OUTCOMES WITH TERUMO’S MISAGO STENT
  • 5.17 UNMET NEEDS AND END-USER EXPECTATIONS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI ON PERIPHERAL VASCULAR DEVICES MARKET
PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
86
ANGIOPLASTY STENTS MARKET, BY TYPE
88
  • 7.1 INTRODUCTION
  • 7.2 DRUG-ELUTING STENTS
    DRUG-ELUTING STENTS TO WITNESS HIGHER ADOPTION
  • 7.3 BARE-METAL STENTS
    BARE-METAL STENTS, BY DELIVERY PLATFORM
    - Balloon-expandable stents
    - Self-expandable stents
ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE
98
  • 8.1 INTRODUCTION
  • 8.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
    RISING PREVALENCE AND NEED FOR TREATMENT TO DRIVE MARKET
  • 8.3 THORACIC AORTIC ANEURYSM STENT GRAFTS
    INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO PROPEL ADOPTION
CATHETERS MARKET, BY TYPE
103
  • 9.1 INTRODUCTION
  • 9.2 ANGIOGRAPHY CATHETERS
    ANGIOGRAPHY CATHETERS TO DOMINATE CATHETERS MARKET
  • 9.3 GUIDING CATHETERS
    GROWING NUMBER OF TARGET PROCEDURES TO DRIVE MARKET
  • 9.4 IVUS/OCT CATHETERS
    IVUS/OCT CATHETERS SEGMENT TO REGISTER HIGHEST GROWTH
INFERIOR VENA CAVA FILTERS MARKET, BY TYPE
110
  • 10.1 INTRODUCTION
  • 10.2 RETRIEVABLE FILTERS
    RETRIEVABLE FILTERS SEGMENT TO REGISTER HIGHER GROWTH
  • 10.3 PERMANENT FILTERS
    RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER SALES
ANGIOPLASTY BALLOONS MARKET, BY TYPE
115
  • 11.1 INTRODUCTION
  • 11.2 OLD/NORMAL BALLOONS
    OLD/NORMAL BALLOONS TO DOMINATE ANGIOPLASTY BALLOONS MARKET
  • 11.3 DRUG-ELUTING BALLOONS
    DRUG-ELUTING BALLOONS TO WITNESS HIGHEST GROWTH
  • 11.4 CUTTING & SCORING BALLOONS
    PREFERENCE FOR MEDICATION AS PRIMARY TREATMENT FOR ATHEROSCLEROSIS TO RESTRAIN ADOPTION
PLAQUE MODIFICATION DEVICES MARKET, BY TYPE
123
  • 12.1 INTRODUCTION
  • 12.2 ATHERECTOMY DEVICES
    INCREASING INCIDENCE OF ATHEROSCLEROSIS TO DRIVE MARKET
  • 12.3 THROMBECTOMY DEVICES
    GROWING DVT INCIDENCE TO DRIVE ADOPTION OF THROMBECTOMY DEVICES
HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE
129
  • 13.1 INTRODUCTION
  • 13.2 EMBOLIC PROTECTION DEVICES
    INVESTMENTS IN TECHNOLOGICAL ADVANCEMENTS AND GROWING REGULATORY APPROVALS TO DRIVE MARKET
  • 13.3 CHRONIC TOTAL OCCLUSION DEVICES
    RISING SUPPORT FOR DEVICE DEVELOPMENT TO DRIVE MARKET
OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
134
  • 14.1 INTRODUCTION
  • 14.2 GUIDEWIRES
    GUIDEWIRES TO HOLD LARGEST MARKET SHARE
  • 14.3 VASCULAR CLOSURE DEVICES
    TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
  • 14.4 INTRODUCER SHEATHS
    POTENTIAL FOR REDUCING ARTERIAL DAMAGE TO DRIVE ADOPTION
  • 14.5 BALLOON INFLATION DEVICES
    INTEGRATED TECHNOLOGIES AND RISING NUMBER OF TARGET PROCEDURES TO PROPEL ADOPTION
PERIPHERAL VASCULAR DEVICES MARKET, BY REGION
142
  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Favorable reimbursement scenario to contribute to growth
    CANADA
    - Increasing cases of chronic conditions to fuel market
  • 15.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Statutory health insurance policy to support growth
    FRANCE
    - Growing geriatric population to drive market
    UK
    - Increasing volume of coronary angioplasty procedures to sustain growth
    SPAIN
    - Growing cases of diabetes and obesity to boost market
    ITALY
    - Increasing prevalence of atherosclerotic cardiovascular disease to spur growth
    REST OF EUROPE
  • 15.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Large geriatric population to ensure sustained demand
    CHINA
    - Growing incidence of lifestyle diseases to fuel market
    INDIA
    - Rising prevalence of target diseases and growing healthcare expenditure to propel market
    AUSTRALIA
    - High prevalence of cardiovascular and peripheral artery diseases to drive market
    SOUTH KOREA
    - Rising rates of chronic diseases to boost market
    REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Rising healthcare expenditure to aid growth
    MEXICO
    - Increasing prevalence of cardiovascular diseases to spur growth
    COLOMBIA
    - Growing incidence of peripheral artery diseases to expedite growth
    ARGENTINA
    - Increasing prevalence of peripheral artery diseases to support market growth
    REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Rising cases of hypertension and associated cardiovascular diseases to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
235
  • 16.1 INTRODUCTION
  • 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 16.3 REVENUE ANALYSIS
  • 16.4 MARKET SHARE ANALYSIS
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Type footprint
    - Region footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    RESPONSIVE COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 16.7 BRAND/PRODUCT COMPARISON
  • 16.8 COMPANY VALUATION AND FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 16.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
COMPANY PROFILES
252
  • 17.1 KEY PLAYERS
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    B. BRAUN SE
    - Business overview
    - Products offered
    MERIT MEDICAL SYSTEMS
    - Business overview
    - Products offered
    - Recent developments
    PENUMBRA, INC.
    - Business overview
    - Products offered
    - Recent developments
    KONINKLIJKE PHILIPS NV
    - Business overview
    - Products offered
    - Recent developments
    STRYKER
    - Business overview
    - Products offered
    CORDIS
    - Business overview
    - Products offered
    - Recent developments
    COOK
    - Business overview
    - Products offered
    - Recent developments
    W. L. GORE & ASSOCIATES, INC.
    - Business overview
    - Products offered
    - Recent developments
    BIOSENSORS INTERNATIONAL GROUP, LTD.
    - Business overview
    - Products offered
    IVASCULAR
    - Business overview
    - Products offered
    BIOTRONIK
    - Business overview
    - Products offered
    - Recent developments
    ENDOLOGIX
    - Business overview
    - Products offered
    ENDOCOR GMBH & CO., KG
    - Business overview
    - Products offered
  • 17.2 OTHER PLAYERS
    MERIL LIFE SCIENCES PVT. LTD.
    ALVIMEDICA
    CARDIONOVUM GMBH
    SMT
    MEDINOL
    ANDRAMED GMBH
    REX MEDICAL
    QMD INC.
    BROSMED MEDICAL CO., LTD.
    ELIXIR MEDICAL
APPENDIX
315
  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 PERIPHERAL VASCULAR DEVICES MARKET: ASSUMPTION ANALYSIS
  • TABLE 3 PERIPHERAL VASCULAR DEVICES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030
  • TABLE 5 US: REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES
  • TABLE 6 DIABETIC POPULATION, BY REGION, 2019 VS. 2030
  • TABLE 7 TOP 10 COUNTRIES WITH HIGHEST SMOKING RATE (2021)
  • TABLE 8 OBESITY RATE, BY COUNTRY (2022)
  • TABLE 9 PERIPHERAL VASCULAR DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PERIPHERAL VASCULAR DEVICES
  • TABLE 11 KEY BUYING CRITERIA FOR PERIPHERAL VASCULAR DEVICES
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 HS CODES FOR PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 18 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 19 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 20 AVERAGE SELLING PRICE TREND OF PERIPHERAL VASCULAR DEVICES, BY REGION, BY TYPE 2021–2023 (USD)
  • TABLE 21 AVERAGE SELLING PRICE OF PERIPHERAL VASCULAR DEVICE, BY KEY PLAYER (2023)
  • TABLE 22 REIMBURSEMENT ANALYSIS FOR PERIPHERAL VASCULAR PROCEDURES
  • TABLE 23 DETAILED LIST OF KEY CONFERENCES AND EVENTS
  • TABLE 24 UNMET NEEDS: PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 25 END-USER EXPECTATIONS: PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 26 AI INTEGRATION: PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 27 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 28 ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 DRUG-ELUTING STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 BARE-METAL STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM, 2022–2029 (USD MILLION)
  • TABLE 33 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 SELF-EXPANDABLE STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 EVAR STENT GRAFTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 AAA STENT GRAFTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 TAA STENT GRAFTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 40 CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 GUIDING CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 IVUS/OCT CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 45 INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 49 ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 OLD/NORMAL BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 DRUG-ELUTING BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 CUTTING & SCORING BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 54 PLAQUE MODIFICATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 58 EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 61 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 GUIDEWIRES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 INTRODUCER SHEATHS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 BALLOON INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 70 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 74 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 75 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 US: MACROECONOMIC INDICATORS
  • TABLE 77 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 US: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 81 US: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 85 CANADA: MACROECONOMIC INDICATORS
  • TABLE 86 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 CANADA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 CANADA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 EUROPE: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 104 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 GERMANY: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 GERMANY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 113 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 FRANCE: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 FRANCE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 UK: MACROECONOMIC INDICATORS
  • TABLE 122 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION
  • TABLE 123 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 UK: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 UK: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 131 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 SPAIN: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 SPAIN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 ITALY: MACROECONOMIC INDICATORS
  • TABLE 140 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 ITALY: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 ITALY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION)
  • TABLE 149 REST OF EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 REST OF EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 REST OF EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 REST OF EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 REST OF EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 JAPAN: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 JAPAN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION
  • TABLE 175 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 CHINA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 CHINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 INDIA: MACROECONOMIC INDICATORS
  • TABLE 183 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 INDIA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 INDIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 192 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 195 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 AUSTRALIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 AUSTRALIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 201 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 SOUTH KOREA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 205 SOUTH KOREA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 SOUTH KOREA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 SOUTH KOREA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 SOUTH KOREA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 215 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 227 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 BRAZIL: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 BRAZIL: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 236 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 237 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 MEXICO: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 MEXICO: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 COLOMBIA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 COLOMBIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 254 ARGENTINA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 ARGENTINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 REST OF LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 GCC COUNTRIES: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 PERIPHERAL VASCULAR DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 294 PERIPHERAL VASCULAR DEVICES MARKET: TYPE FOOTPRINT
  • TABLE 295 PERIPHERAL VASCULAR DEVICES MARKET: REGION FOOTPRINT
  • TABLE 296 PERIPHERAL VASCULAR DEVICES MARKET: KEY STARTUPS/SMES
  • TABLE 297 PERIPHERAL VASCULAR DEVICES MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 298 PERIPHERAL VASCULAR DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 299 PERIPHERAL VASCULAR DEVICES MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 300 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 301 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 302 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2021– AUGUST 2024
  • TABLE 303 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 304 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021– AUGUST 2024
  • TABLE 305 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 306 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 307 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 308 MEDTRONIC: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 309 ABBOTT: COMPANY OVERVIEW
  • TABLE 310 ABBOTT: PRODUCTS OFFERED
  • TABLE 311 ABBOTT: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 312 ABBOTT: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 313 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 314 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 315 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 316 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 317 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, JANUARY 2021– AUGUST 2024
  • TABLE 318 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 319 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 320 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 321 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 322 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 323 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
  • TABLE 324 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
  • TABLE 325 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 326 PENUMBRA, INC.: COMPANY OVERVIEW
  • TABLE 327 PENUMBRA, INC.: PRODUCTS OFFERED
  • TABLE 328 PENUMBRA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021– AUGUST 2024
  • TABLE 329 KONINKLIJKE PHILIPS NV: COMPANY OVERVIEW
  • TABLE 330 KONINKLIJKE PHILIPS NV: PRODUCTS OFFERED
  • TABLE 331 KONINKLIJKE PHILIPS NV: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 332 KONINKLIJKE PHILIPS NV: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 333 STRYKER: COMPANY OVERVIEW
  • TABLE 334 STRYKER: PRODUCTS OFFERED
  • TABLE 335 CORDIS: COMPANY OVERVIEW
  • TABLE 336 CORDIS: PRODUCTS OFFERED
  • TABLE 337 CORDIS: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 338 CORDIS: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2024
  • TABLE 339 COOK: COMPANY OVERVIEW
  • TABLE 340 COOK: PRODUCTS OFFERED
  • TABLE 341 COOK: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 342 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
  • TABLE 343 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 344 W. L. GORE & ASSOCIATES, INC: PRODUCT APPROVALS, JANUARY 2021– AUGUST 2024
  • TABLE 345 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW
  • TABLE 346 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED
  • TABLE 347 IVASCULAR: COMPANY OVERVIEW
  • TABLE 348 IVASCULAR: PRODUCTS OFFERED
  • TABLE 349 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 350 BIOTRONIK: PRODUCTS OFFERED
  • TABLE 351 BIOTRONIK: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 352 ENDOLOGIX: COMPANY OVERVIEW
  • TABLE 353 ENDOLOGIX: PRODUCTS OFFERED
  • TABLE 354 ENDOCOR GMBH & CO., KG: COMPANY OVERVIEW
  • TABLE 355 ENDOCOR GMBH & CO., KG: PRODUCTS OFFERED
  • TABLE 356 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 357 ALVIMEDICA: COMPANY OVERVIEW
  • TABLE 358 CARDIONOVUM GMBH: COMPANY OVERVIEW
  • TABLE 359 SMT: COMPANY OVERVIEW
  • TABLE 360 MEDINOL: COMPANY OVERVIEW
  • TABLE 361 ANDRAMED GMBH: COMPANY OVERVIEW
  • TABLE 362 REX MEDICAL: COMPANY OVERVIEW
  • TABLE 363 QMD INC.: COMPANY OVERVIEW
  • TABLE 364 BROSMED MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 365 ELIXIR MEDICAL: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MARKETS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 6 TOP-DOWN APPROACH
  • FIGURE 7 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 8 PERIPHERAL VASCULAR DEVICES MARKET: CAGR PROJECTIONS (2024–2029)
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 EVAR STENT GRAFTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 CATHETERS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHIC SNAPSHOT OF PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 18 GROWING GERIATRIC POPULATION AND RISING INCREASE IN DISEASE PREVALENCE TO DRIVE MARKET
  • FIGURE 19 DRUG-ELUTING STENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 20 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 21 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 KEY TRENDS IN MARKET: TECHNOLOGICAL ADVANCEMENTS AND SHIFT TOWARD MINIMALLY INVASIVE SURGERIES
  • FIGURE 23 PERIPHERAL VASCULAR DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 24 PERIPHERAL VASCULAR DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 PERIPHERAL VASCULAR DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 PERIPHERAL VASCULAR DEVICES MARKET: PORTER’S FIVE FORCE ANALYSIS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PERIPHERAL VASCULAR DEVICES
  • FIGURE 28 KEY BUYING CRITERIA FOR PERIPHERAL VASCULAR DEVICES
  • FIGURE 29 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014-MARCH 2024)
  • FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) PATENTS (JANUARY 2014- AUGUST 2024)
  • FIGURE 31 PERIPHERAL VASCULAR DEVICES MARKET: INVESTMENT & FUNDING SCENARIO (2018–2023)
  • FIGURE 32 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
  • FIGURE 34 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET
  • FIGURE 35 REVENUE ANALYSIS FOR KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET (2019–2023)
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET (2023)
  • FIGURE 37 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 38 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 39 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 40 PERIPHERAL VASCULAR DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 44 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 45 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 46 BECTON, DICKISON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 47 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 48 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 49 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • FIGURE 50 PENUMBRA, INC.: COMPANY SNAPSHOT
  • FIGURE 51 KONINKLIJKE PHILIPS NV: COMPANY SNAPSHOT
  • FIGURE 52 STRYKER: COMPANY SNAPSHOT

The study involved four major activities to estimate the current size of the Peripheral vascular devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Peripheral vascular devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the Peripheral vascular devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Peripheral vascular devices market.; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents:

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue.

As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the transfection technologies market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The research methodology used to estimate the size of the Peripheral vascular devices market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Peripheral vascular devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Peripheral vascular devices market was obtained from secondary data and validated by primary participants to arrive at the total Peripheral vascular devices market. Primary participants further validated the numbers.

Geographic market assessment (by region & country):The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Peripheral vascular devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Peripheral vascular devices market.

Market Definition

Peripheral vascular devices are medical equipment and instruments used in the diagnosis, treatment, or management of peripheral blood vessel illnesses of the patient. It pertains to diseases, disease, or disorders involving the arteries, veins, and lymphatic vessels outside the heart and brain. The overall application of peripheral vascular devices is in treating PAD and DVT, as well as other vascular disorders. It facilitates procedures that are intended to restore normal blood flow, remove clots, and keep the vessel open. Examples include balloon catheters, stents, guidewires, atherectomy devices, and vascular grafts.

Stakeholders

  • Medical Device Manufacturers
  • Cardiologists
  • Interventional Cardiologist
  • Healthcare institutions (hospitals and outpatient clinics)
  • Distributors and suppliers
  • Research institutes
  • Health insurance payers
  • Market research and consulting firms

Report Objectives

  • To define, describe, segment, and forecast the global Peripheral vascular devices market by types and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Peripheral vascular devices market.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the Peripheral vascular devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the global Peripheral vascular devices market and comprehensively analyze their core competencies2 and market shares.
  • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
  • To benchmark players within the Peripheral vascular devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Previous Versions of this Report

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) - Global Forecast to 2026

Report Code MD 1254
Published in Dec, 2021, By MarketsandMarkets™

Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration, IVC Filters, Guidewires), and Region - Global Forecast to 2025

Report Code MD 1254
Published in Jul, 2020, By MarketsandMarkets™

Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2024

Report Code MD 1254
Published in Feb, 2019, By MarketsandMarkets™

Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2022

Report Code MD 1254
Published in Jan, 2018, By MarketsandMarkets™

Interventional Cardiology & Peripheral Vascular Devices Market To 2016 (Embolic Protection, Chronic Total Occlusion, Coronary Atherectomy, Thrombectomy Devices, IVUS & Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessory Devices) – Global Trends & Competitive Analysis

Report Code MD 1254
Published in Jul, 2012, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Peripheral Vascular Devices Market

DMCA.com Protection Status